Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apellis Pharmaceuticals (APLS) Capital Expenditures (2020 - 2025)

Apellis Pharmaceuticals filings provide 6 years of Capital Expenditures readings, the most recent being $108000.0 for Q4 2025.

  • For the quarter ending Q4 2025, Capital Expenditures rose 440.0% year-over-year to $108000.0, compared with a TTM value of $313000.0 through Dec 2025, down 22.33%, and an annual FY2025 reading of $313000.0, down 22.33% over the prior year.
  • Capital Expenditures hit $108000.0 in Q4 2025 for Apellis Pharmaceuticals, down from $148000.0 in the prior quarter.
  • The five-year high for Capital Expenditures was $851000.0 in Q4 2022, with the low at $8000.0 in Q1 2025.
  • Median Capital Expenditures over the past 5 years was $148000.0 (2025), compared with a mean of $216631.6.
  • The sharpest move saw Capital Expenditures crashed 97.33% in 2021, then soared 4378.95% in 2022.
  • Year by year, Capital Expenditures stood at $19000.0 in 2021, then surged by 4378.95% to $851000.0 in 2022, then plummeted by 88.84% to $95000.0 in 2023, then crashed by 78.95% to $20000.0 in 2024, then skyrocketed by 440.0% to $108000.0 in 2025.
  • According to Business Quant data, Capital Expenditures over the past three periods came in at $108000.0, $148000.0, and $49000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.